Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046
- PMID: 40091108
- PMCID: PMC11912679
- DOI: 10.1186/s40779-025-00599-y
Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046
Keywords: Disability-adjusted life-years (DALYs); Global burden of disease; Health inequality; Urinary tumors.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.
Figures
References
-
- Ren J, Song M, Zhang W, Cai JP, Cao F, Cao Z, et al. The aging biomarker consortium represents a new era for aging research in China. Nat Med. 2023;29(9):2162–5. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - PubMed
-
- GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2133–61. - PMC - PubMed
-
- Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
